Authors Guideline
Authorship criteria
The journal follows ICMJE criteria for authorship status which recommends that authorship be based on following 4 criteria:
1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
2. Drafting the work or revising it critically for important intellectual content; AND
3. Final approval of the version to be published; AND
4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All those designated as authors should meet all four criteria for authorship and all who meet the four criteria should be identified as authors.
Non-Author Contributors
All those contributors who do not meet all four criteria for authorship should not be listed as authors, but they should be acknowledged.
Conflict of Interest
All authors must disclose any and all conflicts of interest they may have with publication of the manuscript or an institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose conflict of interest with products that compete with those mentioned in their manuscript. Preparation of Manuscripts Manuscripts must be prepared in accordance with “uniform requirements for manuscripts submitted to Biomedical Journals” developed by ICMJE. The uniform and specific requirements of International Journal of Society of Medical sciences and Research are summarised below.
Article types
the following type of manuscripts are routinely accepted. Original research article Manuscript must be accompanied by covering letter, introducing the manuscript and confirming that it is not being submitted concurrently elsewhere.
Manuscript should contain the following headings
a. Abstract: It should be structured and briefly mentions background, objectives, material & amp; method, results, conclusion and keywords. It should not exceed 250 words.
b. Introduction: it should state the background and purpose of the study and also summarise the problem statement, rationale and Objectives of the study.
Material and Methods: It should include the following aspects
Study design: Selection and Description of Participants: Describe your selection of the observational or experimental participants (healthy people, patients or laboratory animals, including controls) clearly, including eligibility and exclusion criteria and a description of the source population. Technical information: Identify the methods, apparatus (give the manufacturer's name and address in parentheses), and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods (see below); provide references and brief descriptions for methods that have been published but are not well known; describe new or substantially modified methods, give reasons for using them, and evaluate their limitations. Identify precisely all drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration.
Reporting should be as per the reporting guidelines for specific study designs
as mentioned below:
Initiative |
Type of Study |
Source |
|||
CONSORT 2010 |
Consolidated Standards of Reporting Trials |
||||
STARD 2015 |
STAndards for the Reporting of Diagnostic accuracy |
||||
PRISMA |
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (formerly, the QUOROM statement) |
||||
STROBE |
Observational studies in epidemiology |
||||
MOOSE |
Meta-analyses of observational studies in epidemiology |
||||
CARE |
Case Reports |
||||
|
Used to report "economic evaluations of health interventions." |
||||
TRIPOD |
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis. |
http://www.equator-network.org/reporting-guidelines/tripod-statement/ |
Statistics: Whenever possible quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Authors should report losses to observation (such as, dropouts from a clinical trial). When data are summarized in the Results section, specify the statistical methods used to analyze them. Avoid non-technical uses of technical terms in statistics, such as 'random' (which implies a randomizing device), 'normal', 'significant', 'correlations', and 'sample'. Define statistical terms, abbreviations, and most symbols. Specify the computer software used. Use upper italics (P 0.048). For all P values include the exact value and not less than 0.05 or 0.001. Mean differences in continuous variables, proportions in categorical variables and relative risks including odds ratios and hazard ratios should be accompanied by their confidence intervals.
Results: Present your results in a logical sequence in the text, tables, and illustrations, giving the main or most important findings first. Only important findings to be mentioned in text. Extra- or supplementary materials and technical detail can be placed in an appendix.
Discussion: Include summary of key findings (primary outcome measures, secondary outcome measures, results as they relate to a prior hypothesis); Strengths and limitations of the study (study question, study design, data collection, analysis and interpretation); Interpretation and implications in the context of the totality of evidence (is there a systematic review to refer to, if not, could one be reasonably done here and now?, what this study adds to the available evidence, effects on patient care and health policy, possible mechanisms); Controversies raised by this study; and Future research directions (for this particular research collaboration, underlying mechanisms, clinical research).
Review Article
It is expected that these articles would be written by individuals who have done substantial work on the subject or are considered experts in the field. A short summary of the work done by the contributor(s) in the field of review should accompany the manuscript.
The prescribed word count is up to 3000 words excluding tables, references and abstract. The manuscript may have about 90 references. The manuscript should have an unstructured Abstract (250 words) representing an accurate summary of the article. The section titles would depend upon the topic reviewed. Authors submitting review article should include a section describing the methods used for locating, selecting, extracting, and synthesizing data. These methods should also be summarized in the abstract.
Case reports:
New, interesting and rare cases can be reported. They should be unique, describing a great diagnostic or therapeutic challenge and providing a learning point for the readers. Cases with clinical significance or implications and of educational value will be given priority. These communications could be of up to 1000 words (excluding Abstract and references) and should have the following headings: Abstract (unstructured), Key-words, Introduction, Case report, Discussion, Reference, Tables and Legends in that order.
Case Series:
The journal also accepts series of interesting and clinically useful cases. The manuscript could be of up to 1800 words (excluding references and abstract) and could be supported with up to 15 references. Case Reports could be authored by up to four authors. Cases with clinical significance or implications and of educational value will be given priority. These communications could be of up to 1000 words (excluding Abstract and references) and should have the following headings: Abstract (unstructured), Key-words, Introduction, Case report, Discussion, Reference, Tables and Legends in that order.
Letter to the Editor:
They should be short and decisive and be related to articles previously published (including editorials/commentaries) in the Journal or views expressed in the journal. They should not be preliminary observations that need a later paper for validation nor can it be case reports. The letter could have up to 500 words and maximum of 5 references. It could be generally authored by not more than four authors if reporting a new data. However for any letter in response to a published paper in JFMPC, there should be preferably only one author and not more than two authors.
Manuscript submission
All the article will be submitted to journal through online submissions.
Registration and login are required to submit manuscript and to check the status of manuscript.
Submission checklist
During the submission process, authors are requested to check their submission's compliance with all of the following items, and same may be returned to authors that do not follow these instructions.
- The submission has neither been previously published/accepted, nor it is under consideration in any another journal.
- The author should mention about the publication of abstract as conference proceeding in any journal/book as comments to Editor during submission process.
- The submission file should be in Microsoft office Word document file format.
- The text is double-spaced; uses a 12-point font in Times New Roman;; and all illustrations, figures, and tables are placed within the text at the appropriate points.
- References/Bibliography should follow Vancouver style and refrence number should be included as in text citation and where available, doi for the references should be written.
- The text is double-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
Article publishing charges
Type of article |
Member India |
Member International |
Non member |
Non-member International |
Original/ Review/ Special article |
INR 2000 |
USD 40 |
INR 3000 |
USD 60 |
Brief research article/ Commentary/short communication |
INR 1500 |
USD 30 |
INR 2000 |
USD 50 |
Case Report |
1000 |
USD 20 |
INR 1500 |
USD 40 |
Case series |
1500 |
USD 30 |
2000 |
USD 50 |
Letter to editors (others) |
INR 1000 |
USD 20 |
INR 1500 |
USD 40 |